EFFECT OF PREGNENOLONE-16-ALPHA-CARBONITRILE AND DEXAMETHASONE ON ACETAMINOPHEN-INDUCED HEPATOTOXICITY IN MICE

被引:28
作者
MADHU, C
MAZIASZ, T
KLAASSEN, CD
机构
[1] Environmental Health and Occupational Medicine Center, Department of Pharmacology, Toxicology and Therapeutics, Kansas City
关键词
D O I
10.1016/0041-008X(92)90323-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recently, we demonstrated that a microsomal enzyme inducer with a steroidal structure, pregnenolone-16α-carbonitrile (PCN), markedly decreased the hepatotoxicity of acetaminophen (AA) in hamsters. Therefore, it was of interest to determine if PCN, as well as another steroid microsomal enzyme inducer, dexamethasone (DEX), would decrease the toxicity of AA in mice, another species sensitive to AA hepatotoxicity. Mice were pretreated with PCN or DEX (100 and 75 mg/kg, ip, for 4 days, respectively) and were given AA (300-500 mg/kg, ip). Twenty-four hours after AA administration, liver injury was assessed by measuring serum activities of sorbitol dehydrogenase and alanine aminotransferase and by histopathological examination. Neither PCN nor DEX protected markedly against AA hepatotoxicity in mice; PCN tended to decrease AA-induced hepatotoxicity, whereas DEX was found to enhance AA-induced hepatotoxicity and it produced some hepatotoxicity itself. DEX decreased the glutathione concentration (36%) in liver and increased the biliary excretion of AA-GSH, which reflects the activation of AA, whereas PCN produced neither effect. Thus, whereas PCN has been shown to markedly decrease the hepatotoxicity of AA in hamsters, apparently by decreasing the isoform of P450 responsible for activating AA to N-acetyl-p-benzoquinoneimine, this does not occur in mice after induction with either PCN or DEX. In contrast, DEX enhances AA hepatotoxicity apparently by decreasing liver GSH levels and increasing the activation of AA to a cytotoxic metabolite. © 1992.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 47 条
[1]  
ASADA M, 1963, GASTROENTEROLOGY, V44, P578
[2]   ACETAMINOPHEN HEPATOTOXICITY [J].
BLACK, M .
ANNUAL REVIEW OF MEDICINE, 1984, 35 :577-593
[3]  
BORNHEIM LM, 1990, MOL PHARMACOL, V38, P319
[4]   LIVER NECROSIS FROM PARACETAMOL [J].
BOYD, EM ;
BERECZKY, GM .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1966, 26 (03) :606-&
[5]  
Chalkley HW, 1943, J NATL CANCER I, V4, P47
[6]  
COLDWELL BB, 1976, P EUROPEAN SOC TOXIC, V17, P269
[7]  
CORCORAN GB, 1980, MOL PHARMACOL, V18, P536
[8]   N-ACETYL-PARA-BENZOQUINONE IMINE - A CYTOCHROME-P-450-MEDIATED OXIDATION-PRODUCT OF ACETAMINOPHEN [J].
DAHLIN, DC ;
MIWA, GT ;
LU, AYH ;
NELSON, SD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (05) :1327-1331
[9]   ACUTE LIVER NECROSIS FOLLOWING OVERDOSE OF PARACETAMOL [J].
DAVIDSON, DG ;
EASTHAM, WN .
BRITISH MEDICAL JOURNAL, 1966, 2 (5512) :497-&
[10]   SPECIES-DIFFERENCES IN HEPATIC GLUTATHIONE DEPLETION, COVALENT BINDING AND HEPATIC NECROSIS AFTER ACETAMINOPHEN [J].
DAVIS, DC ;
POTTER, WZ ;
JOLLOW, DJ ;
MITCHELL, JR .
LIFE SCIENCES, 1974, 14 (11) :2099-2109